Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Enjoy this offer
* See conditions on site
Capitalization 5.67B 6.71B P/E ratio 2024 *
48.9x
P/E ratio 2025 * 37.8x
Enterprise value 4.57B 5.41B EV / Sales 2024 *
8.99x
EV / Sales 2025 * 7.35x
Free-Float
94.31%
Yield 2024 *
1.14%
Yield 2025 * 1.27%
More valuation ratios * Estimated data
Dynamic Chart
1 day+0.36%
1 week-2.44%
Current month-6.22%
1 month-5.47%
3 months-1.55%
6 months-7.08%
Current year+17.08%
More quotes
1 week
75.00
Extreme 75
78.10
1 month
75.00
Extreme 75
84.70
Current year
53.95
Extreme 53.95
91.65
1 year
53.95
Extreme 53.95
91.65
3 years
49.90
Extreme 49.9
171.00
5 years
27.52
Extreme 27.52
171.00
10 years
8.31
Extreme 8.31
171.00
More quotes
Director TitleAgeSince
Chief Executive Officer 56 18-12-31
Director of Finance/CFO 47 21-01-31
Chief Tech/Sci/R&D Officer - 02-12-31
Manager TitleAgeSince
Director/Board Member 82 -
Director/Board Member 51 11-04-12
Chairman 68 12-04-24
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
+0.36%-2.44%+2.98%-46.48%6.7B
-1.00%+0.41%+11.29%-28.83%46.68B
-2.35%-5.47%+10.15%-9.71%42.88B
+1.20%+0.96%+27.20%+35.17%32.89B
+1.93%-0.61%+32.75%-22.35%30.1B
+3.49%+8.69%-26.35%-82.36%30.47B
-6.10%-10.17%+12.13%+8.37%23.23B
-1.79%-2.82%+52.12%+62.87%15.24B
+2.34%+2.86%+2.73%-42.89%11.7B
-3.41%-6.32%+20.91%+70.99%10.14B
Average -0.53%-1.32%+14.59%-5.52% 25B
Weighted average by Cap. -0.47%-0.61%+13.52%-10.91%
See all sector performances
2024 *2025 *
Net sales 623M 737M 786M 931M
Net income 114M 135M 151M 179M
Net Debt -73.9M -87.47M 109M 129M
More financial data * Estimated data
Logo Bachem Holding AG
Bachem Holding AG is a Switzerland-based biochemical company that provides services to the pharmaceutical and biotechnology industry. The Company focuses on the process development and manufacturing of peptides and organic molecules as active pharmaceutical ingredients (APIs), as well as on the development of biochemical products for research purposes. Its product portfolio comprises fluorescent dyes for the fluorescence energy transfer (FRET) analysis of receptor-ligand interactions, protein-protein interactions and the cleavage of substrate molecules, as well as glycosylated peptides for the manipulation of drug properties. The Company markets products under the Bachem and Clinalfa brands and operates production facilities in Switzerland and in the United States.
Employees
2,009
More about the company
Date Price Change Volume
24-09-11 77.30 CHF +2.18% 13,565
24-09-10 75.65 CHF -1.37% 49,305
24-09-09 76.70 CHF +2.06% 73,762
24-09-06 75.15 CHF -1.12% 55,255
24-09-05 76.00 CHF -2.56% 38,255

Delayed Quote Swiss Exchange, September 11, 2024 at 03:20 am EDT

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
7
Last Close Price
75.65CHF
Average target price
82.83CHF
Spread / Average Target
+9.50%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW